
    
      The study will be conducted at no less than 10 clinical centers. Patients will be first
      screened, and only after meeting all the selection criteria, not meeting any exclusion
      criteria, and signing the informed consent, could they be enrolled in the group to receive
      BTPNA to sample the target lesions. The primary endpoint is the diagnostic yield of BTPNA.
      The secondary endpoints include the success rate of navigation, the operation time of the
      bronchoscope and so on.
    
  